What is Heartbase?
Heartbase, Inc. operates at the intersection of clinical excellence and operational efficiency, offering a suite of specialized tools designed to streamline cardiovascular data management. With a legacy spanning over three decades, the firm provides hospitals with standardized and custom registries, alongside advanced analytics platforms such as hbCOR, hbNote, and hbAnalytics. These solutions are engineered to facilitate clinician-centered workflows, ensure regulatory compliance, and optimize financial performance through precise coding reconciliation. By focusing on the specific needs of cardiovascular programs, Heartbase enables medical providers to transform raw clinical data into actionable insights, ultimately driving improvements in patient care outcomes and institutional productivity.
How much funding has Heartbase raised?
Heartbase has raised a total of $375K across 2 funding rounds:
Debt
$150K
Debt
$225K
Debt (2020): $150K with participation from PPP
Debt (2021): $225K led by PPP
Key Investors in Heartbase
PPP
Public-Private Partnership
What's next for Heartbase?
With the successful completion of this late-stage capital injection, Heartbase is well-positioned to accelerate its strategic roadmap. The company is expected to focus on scaling its analytics capabilities and expanding its footprint within the national healthcare landscape. As hospitals increasingly prioritize data-driven decision-making to manage rising costs and improve clinical quality, Heartbase's emphasis on interoperability and user-centric design will likely serve as a key differentiator. Future growth initiatives will likely involve deepening its integration with existing electronic health record systems and enhancing its predictive modeling toolkits to meet the evolving demands of modern cardiovascular care environments.
See full Heartbase company page
